Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2005 | 2 |
2006 | 3 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
TP53 and P21 polymorphisms: response to cisplatinum/paclitaxel-based chemotherapy in ovarian cancer.
Biochem Biophys Res Commun. 2006 Feb 3;340(1):256-62. doi: 10.1016/j.bbrc.2005.11.176. Epub 2005 Dec 9.
Biochem Biophys Res Commun. 2006.
PMID: 16364249
TP53 codon 72 polymorphism and risk for cervical cancer in Portugal.
Santos AM, Sousa H, Catarino R, Pinto D, Pereira D, Vasconcelos A, Matos A, Lopes C, Medeiros R.
Santos AM, et al.
Cancer Genet Cytogenet. 2005 Jun;159(2):143-7. doi: 10.1016/j.cancergencyto.2004.10.005.
Cancer Genet Cytogenet. 2005.
PMID: 15899386
Item in Clipboard
Linking TP53 codon 72 and P21 nt590 genotypes to the development of cervical and ovarian cancer.
Santos AM, Sousa H, Pinto D, Portela C, Pereira D, Catarino R, Duarte I, Lopes C, Medeiros R.
Santos AM, et al.
Eur J Cancer. 2006 May;42(7):958-63. doi: 10.1016/j.ejca.2006.01.015. Epub 2006 Mar 20.
Eur J Cancer. 2006.
PMID: 16542834
Item in Clipboard
Linkage of TP53 codon 72 pro/pro genotype as predictive factor for nasopharyngeal carcinoma development.
Sousa H, Santos AM, Catarino R, Pinto D, Vasconcelos A, Lopes C, Breda E, Medeiros R.
Sousa H, et al. Among authors: santos am.
Eur J Cancer Prev. 2006 Aug;15(4):362-6. doi: 10.1097/00008469-200608000-00010.
Eur J Cancer Prev. 2006.
PMID: 16835507
Item in Clipboard
Cite
Cite